The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.
作者信息
Richards A M
机构信息
Department of Medicine, Christchurch Hospital, New Zealand.
出版信息
Heart. 1996 Nov;76(3 Suppl 3):36-44. doi: 10.1136/hrt.76.3_suppl_3.36.
Abstract
摘要
相似文献
1
The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.肾素-血管紧张素-醛固酮系统与心钠素
Heart. 1996 Nov;76(3 Suppl 3):36-44. doi: 10.1136/hrt.76.3_suppl_3.36.
2
3
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists.
Am J Med. 1989 Dec 26;87(6B):24S-28S. doi: 10.1016/0002-9343(89)90087-9.
4
Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.心房利钠肽：血压和电解质稳态激素调控中的一个新因子。
Annu Rev Med. 1986;37:397-414. doi: 10.1146/annurev.me.37.020186.002145.
5
The natriuretic peptides in hypertension.高血压中的利钠肽
Curr Opin Cardiol. 1995 Sep;10(5):495-500. doi: 10.1097/00001573-199509000-00009.
6
Modulation of the renin-angiotensin system by atrial natriuretic peptide.心房利钠肽对肾素-血管紧张素系统的调节作用。
J Cardiovasc Pharmacol. 1990;16 Suppl 7:S43-6.
7
Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.心房利钠因子对血压及肾素-血管紧张素-醛固酮系统的影响。
Fed Proc. 1986 Jun;45(7):2115-21.
8
Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.心房、脑和 C 型利钠肽在清醒绵羊体内的比较生物活性
Am J Physiol. 1996 Jun;270(6 Pt 2):R1324-31. doi: 10.1152/ajpregu.1996.270.6.R1324.
9
10
Natriuretic peptides.利钠肽
N Engl J Med. 1998 Jul 30;339(5):321-8. doi: 10.1056/NEJM199807303390507.
引用本文的文献
1
Association between serum corin levels and functional capacity in patients with advanced heart failure.晚期心力衰竭患者血清Corin水平与功能能力之间的关联。
Biomark Med. 2025 Jun;19(11):395-403. doi: 10.1080/17520363.2025.2511473. Epub 2025 May 26.
2
A comprehensive review of heart failure: Unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction.心力衰竭的综合综述：剖析病因，解码病理生理机制，探索诊断方法，探讨药物干预，倡导生活方式改变，并在慢性心脏功能障碍的复杂领域中描绘新兴疗法的前景。
Medicine (Baltimore). 2024 Jan 19;103(3):e36895. doi: 10.1097/MD.0000000000036895.
3
Cardiovascular Consequences of Acute Kidney Injury: Treatment Options.急性肾损伤的心血管后果：治疗选择
Biomedicines. 2023 Aug 24;11(9):2364. doi: 10.3390/biomedicines11092364.
4
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.血管紧张素 II 作为一种天然存在的鸟苷酸环化酶 A 受体和环鸟苷酸生成的抑制剂的证据。
Int J Mol Sci. 2023 May 10;24(10):8547. doi: 10.3390/ijms24108547.
5
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms.利钠肽：基于其分子机制的靶向治疗策略的时代已经到来。
Int J Mol Sci. 2023 Mar 7;24(6):5131. doi: 10.3390/ijms24065131.
6
Prior fluid and electrolyte imbalance is associated with COVID-19 mortality.先前的体液和电解质失衡与新冠病毒疾病死亡率相关。
Commun Med (Lond). 2021 Nov 25;1:51. doi: 10.1038/s43856-021-00051-x. eCollection 2021.
7
Pathophysiology of heart failure.心力衰竭的病理生理学
Cardiovasc Diagn Ther. 2021 Feb;11(1):263-276. doi: 10.21037/cdt-20-302.
8
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.蛋白质组学生物标志物和向心力衰竭进展的机制途径。
Circ Heart Fail. 2019 May;12(5):e005897. doi: 10.1161/CIRCHEARTFAILURE.118.005897.
9
Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.心脏交感-迷走神经反应性的环核苷酸调节
J Physiol. 2016 Jul 15;594(14):3993-4008. doi: 10.1113/JP271827. Epub 2016 May 5.
10
Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.心力衰竭的病理生理学及心肾联系。循环激素：生物标志物还是介质。
Clin Chim Acta. 2015 Mar 30;443:3-8. doi: 10.1016/j.cca.2014.10.027. Epub 2014 Oct 23.
本文引用的文献
1
Atrial natriuretic peptide in non-modulating essential hypertension.非调节性原发性高血压中的心房利钠肽
Hypertension. 1993 Jun;21(6 Pt 1):803-9. doi: 10.1161/01.hyp.21.6.803.
2
Atrial natriuretic factor and changes in the aldosterone response to angiotensin II in sodium depleted dogs.心房利钠因子与钠缺乏犬对血管紧张素II的醛固酮反应变化
Clin Exp Hypertens. 1993 Mar;15(2):379-94. doi: 10.3109/10641969309032941.
3
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.在起搏诱导的心力衰竭清醒犬中抑制中性内肽酶3.4.24.11和血管紧张素转换酶期间的全身血流动力学、肾功能和激素水平
J Pharmacol Exp Ther. 1993 Aug;266(2):872-83.
4
Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension.SCH 42495对原发性高血压中内肽酶24.11的抑制作用
Hypertension. 1993 Jul;22(1):119-26. doi: 10.1161/01.hyp.22.1.119.
5
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II.内肽酶24.11在原发性高血压中的慢性抑制作用：心房利钠肽和血管紧张素II增强的证据。
J Hypertens. 1993 Apr;11(4):407-16. doi: 10.1097/00004872-199304000-00011.
6
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.转化酶抑制剂和中性内肽酶抑制剂对实验性高血压血压及肾功能的影响。
J Pharmacol Exp Ther. 1993 Jun;265(3):1339-47.
7
Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension.
J Hypertens. 1993 Feb;11(2):163-70. doi: 10.1097/00004872-199302000-00008.
8
Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.人脑利钠肽对正常男性的肾脏、内分泌及血流动力学影响。
J Clin Endocrinol Metab. 1993 Jan;76(1):91-6. doi: 10.1210/jcem.76.1.8380606.
9
Biochemistry of natriuretic peptides.
J Intern Med. 1994 Jun;235(6):561-76. doi: 10.1111/j.1365-2796.1994.tb01263.x.
10
The natriuretic peptides and hypertension.
J Intern Med. 1994 Jun;235(6):543-60. doi: 10.1111/j.1365-2796.1994.tb01262.x.
Zotero 插件